These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32507341)

  • 1. Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
    DesJardin JT; Kolaitis NA; Kime N; Kronmal RA; Benza RL; Elwing JM; Lammi MR; McConnell JW; Presberg KW; Sager JS; Shlobin OA; De Marco T;
    J Heart Lung Transplant; 2020 Sep; 39(9):945-953. PubMed ID: 32507341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR).
    DesJardin JT; Kime N; Kolaitis NA; Kronmal RA; Lammi MR; Mathai SC; Ventetuolo CE; De Marco T;
    J Heart Lung Transplant; 2024 Jun; 43(6):901-910. PubMed ID: 38360160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Pulmonary Arterial Compliance in Systemic Lupus Erythematosus Patients With Pulmonary Arterial Hypertension.
    Guo X; Lai J; Wang H; Tian Z; Zhao J; Li M; Fang Q; Fang L; Liu Y; Zeng X
    Hypertension; 2020 Oct; 76(4):1161-1168. PubMed ID: 32772648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in pulmonary arterial flow hemodynamics between children and adults with pulmonary arterial hypertension as assessed by 4D-flow CMR studies.
    Schäfer M; Ivy DD; Abman SH; Stenmark K; Browne LP; Barker AJ; Mitchell MB; Morgan GJ; Wilson N; Shah A; Kollengode M; Naresh N; Fonseca B; DiMaria M; Buckner JK; Hunter KS; Kheyfets V; Fenster BE; Truong U
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1091-H1104. PubMed ID: 30822118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.
    Kozu K; Sugimura K; Aoki T; Tatebe S; Yamamoto S; Yaoita N; Shimizu T; Nochioka K; Sato H; Konno R; Satoh K; Miyata S; Shimokawa H
    Heart Vessels; 2018 Aug; 33(8):939-947. PubMed ID: 29441403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
    Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 12. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.
    Chen SL; Zhang H; Xie DJ; Zhang J; Zhou L; Rothman AM; Stone GW
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002837. PubMed ID: 26553699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension.
    D'Alto M; Badagliacca R; Lo Giudice F; Argiento P; Casu G; Corda M; Correale M; Ghio S; Greco A; Lattanzio M; Mercurio V; Paciocco G; Papa S; Prediletto R; Romeo E; Russo MG; Tayar A; Vitulo P; Vizza CD; Golino P; Naeije R
    J Heart Lung Transplant; 2020 Dec; 39(12):1389-1397. PubMed ID: 32933828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function.
    Kawamukai M; Hashimoto A; Koyama M; Nagano N; Nishida J; Mochizuki A; Kouzu H; Muranaka A; Kokubu N; Nagahara D; Yuda S; Tsuchihashi K; Miura T
    Heart Vessels; 2019 Nov; 34(11):1789-1800. PubMed ID: 31119378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension.
    Chouvarine P; Giera M; Kastenmüller G; Artati A; Adamski J; Bertram H; Hansmann G
    Heart; 2020 Sep; 106(17):1332-1341. PubMed ID: 32079620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.
    Hoette S; Creuzé N; Rochitte CE; Simonneau G; Humbert M; Souza R; Chemla D
    Pulmonology; 2019; 25(4):248-251. PubMed ID: 31080042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
    Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
    Weatherald J; Boucly A; Launay D; Cottin V; Prévot G; Bourlier D; Dauphin C; Chaouat A; Savale L; Jaïs X; Jevnikar M; Traclet J; De Groote P; Simonneau G; Hachulla E; Mouthon L; Montani D; Humbert M; Sitbon O
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30209196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure.
    Nagel C; Marra AM; Benjamin N; Blank N; Cittadini A; Coghlan G; Distler O; Denton CP; Egenlauf B; Fiehn C; Fischer C; Harutyunova S; Hoeper MM; Lorenz HM; Xanthouli P; Bossone E; Grünig E
    Arthritis Rheumatol; 2019 May; 71(5):805-816. PubMed ID: 30615302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.